In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist with surgeries, AI is making steady inroads into our hospitals and clinics. Need an online nursing assistant or a watchdog that helps detect dosage errors? There’s an AI application for that.
The advent of AI in healthcare is a promising trend in terms of both patient care and economic efficiency. AI can help us address a forecasted shortage of physicians, particularly in specialty-care fields, while containing the costs of caring for an aging and growing population. A recent study by a team of researchers from the consulting firm Accenture found that the use of 10 promising AI applications could create up to $150 billion in annual savings for U.S. healthcare by 2026.
For an example of the potential of AI in healthcare, we need to look no further than Gustave Roussy, a leading European center for cancer research and care. In a study published this summer in the medical journal The Lancet Oncology, a team of medical researchers from Gustave Roussy and a few other institutions demonstrated that AI can process medical images to extract biological and clinical information to help with immunotherapy treatment, according to a news release on the study.
In this groundbreaking study, the researchers used an algorithm they designed and developed to analyze CT scan images and create a “radiomic signature.” This signature defines the level of lymphocyte infiltration of a tumor — or the degree to which immune cells have moved from the blood into a tumor cell. The radiomic signature also provides a predictive score for the efficacy of immunotherapy in the patient.
Here’s how AI played into this research: Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the study. Then, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, and it established the radiomic signature.
The announcement summarizing the findings of the study notes that in the future, physicians might be able to use imaging to identify biological phenomena in a tumor located in any part of the body without having to perform a biopsy.
At Dell EMC, this research is particularly close to our hearts because we are active supporters of Gustave Roussy.
Image Credit: Dell EMC
News This Week
The COVID-19 pandemic has prompted considerable investigation into how the SARS-CoV-2 Spike protein attaches to a human cell during the infection process, as this knowledge is useful in designing vaccines and therapeutics. Now, a [...]
Scientists have developed protein fragments—called peptides—that fit snugly into a groove on the SARS-CoV-2 Spike protein that it would normally use to access a host cell. These peptides effectively trick the virus into "shaking hands" with a replica rather than with [...]
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology. T-cell immunity is one of [...]
When SARS-CoV-2 first began spreading across the globe, not every lab was equipped to study it directly. The virus behind the current pandemic is highly pathogenic and transmissible, leading the US Centers for Disease [...]
esearchers have detailed a mechanism in the distinctive corona of Covid-19 that could help scientists to rapidly find new treatments for the virus, and quickly test whether existing treatments are likely to work with [...]
Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health. Researchers from Bangladesh, the United States [...]
A team of investigators from the Republic of China has discovered that 6 drugs previously approved by the US Food and Drug Administration (FDA) for other indications could be repurposed to treat or prevent [...]
Graphene is a layer of carbon only one atom thick. Since it was first isolated in 2004, it has found applications in strengthening materials, accelerating electronics, and boosting performance in batteries, among others. It [...]
The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the approval of the first mRNA vaccines, which GlobalData expects will soon impact other indications. This historical landmark could have [...]
A single dose of the Pfizer coronavirus vaccine is “highly protective” after three weeks, according to a study. Researchers at the University of East Anglia (UEA) said the coronavirus vaccine developed by Pfizer and BioNTech was still effective [...]
Summary: Mice exposed to COVID-19 through the nasal passage, researchers noted a rapid and escalated attack on the brain by the virus that triggered a more severe outcome of the infection, even after the lungs [...]
GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they plan to work jointly to [...]
The great hope for drug treatments against Covid-19 – the monoclonal antibodies – are failing against variants of the virus, such as those that have emerged in South Africa and Brazil, scientists have found. [...]
Bandages are great for covering wounds, but they would be much more useful if they could also detect infections. By embedding nanosensors in the fibers of a bandage, University of Rhode Island Assistant Professor [...]